Parkinson’s disease is a long-term brain condition that affects movement, balance, and daily life. It happens when certain ...
Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.
Researchers have identified a key enzyme driving forms of Parkinson's disease, and have shown how blocking it restores normal function in animal and cell models, offering a promising new drug target ...
About 1 million Americans suffer from Parkinson’s disease, with around 90,000 new cases diagnosed each year, according to the Parkinson’s Foundation. The chronic, degenerative brain disorder destroys ...
Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results